Tylenol maker Kenvue plunges on reports the White House plans to link the drug to autism

Justin Sullivan/Getty Images

• Reports on Monday say the White House is planning to link Tylenol use during pregnancy to autism.
• This news pushed shares down for Kenvue, the company behind the pain relief drug.
• Drug companies have been under pressure amid the administration's push to reshape public health initiatives.

The move: Kenvue stock fell as much as 10% on Monday. The Tylenol maker is down 19% year-to-date.

The Chart:

Why: Reports on Monday...